跳至主要内容
临床试验/NCT06176443
NCT06176443已完成不适用

Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass Using a "FundoRing" Fundoplication on Metabolic Outcomes in Type 2 Diabetes Mellitus: a Randomized Controlled Trial

The Society of Bariatric and Metabolic Surgeons of Kazakhstan2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年1月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
2
主要终点
Metabolic improvements of type 2 diabetes

研究概览

简要总结

The purpose of the study is to evaluate the effect of an increased restrictive factor of one gastric anastomosis (OAGB) using a "FundoRing" fundoplication on metabolic outcomes in type 2 diabetes mellitus. The randomized controlled trial compared two interventional procedures: one group - using the original fundoplication procedure to enhance the restrictive effect and another group without fundoplication in the standard version of the OAGB.

详细描述

The randomized controlled trial compared two interventional procedures: one group - using the original fundoplication procedure to enhance the restrictive effect and another group without fundoplication in the standard version of the OAGB.

The purpose of the study is to evaluate the effect of an increased restrictive factor of one gastric anastomosis (OAGB) using a "FundoRing" fundoplication on metabolic outcomes in type 2 diabetes mellitus.

The main hypothesis is that an increase in the restrictive effect will lead to an increase in the metabolic effect and an increase in its persistence over time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI 25-55 kg/m2
  • Patients with Diabetes Mellitus, Type 2

排除标准

  • BMI <25 and >55 kg/m2
  • Patients without Diabetes Mellitus, Type 2
  • History of surgery on the stomach
  • Less than 18 or more than 60 years of age
  • Psychiatric illness
  • Patients unwilling or unable to provide informed consent

结局指标

主要结局

Metabolic improvements of type 2 diabetes

时间窗: Baseline, at 12, 24, 36 months after surgery

Change % of Glycosylated Hemoglobin. A1C level is below 5.7% - full remisson, a level of 5.7% to 6.4% indicates partial remission , and a level of 6.5% or more indicates diabetes

次要结局

  • Change of body mass index(Baseline, at 12, 24, 36 months after surgery)

研究者

发起方
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验